LIST OF PUBLICATIONS: Jean-Yves DARMON, MD
Davido A, Hallali P, Darmon JY, Robinet C, Jullien JL, Corone P. Pleuropericardial cyst two-dimensio-nal echography and C.A.T. scan of a case. Coeur-Paris 1987 ; 18 : 35-8.
Andrivet P, Adnot S, Brun-Buisson C, Chabrier E, Darmon JY, Braquet P, Lemaire F. Involvement ofANF in the acute antidiuresis during PEEP ventilation. J Appl Physiol 1988 ; 65 : 1967-1974.
Saada M, Catoire P, Deleuze P, Darmon JY, Gabriel I, Bonnet F. Diagnosis of severe pulmonary embo-lism by transesophageal echocardiography. Ann Fr Anesth Reanim 1990 ; 9 : 547-49.
Roupie E, Darmon JY, Brochard L, Saada M, Rekik N, Brun-Buisson C. Fluconazole therapy of candidalnative valve endocarditis. Eur J Clin Microbiol Inf Dis 1991 ; 10 : 458-59.
Darmon JY, Rauss A, Dreyfuss D, Bleichneir G, Elkharrat D, Schlemmer B, Tenaillon A, Brun-Buisson C, Huet Y. Evaluation of risk factors for laryngeal edema after tracheal extubation inadults and its prevention by dexamethasone. A placebo-controlled, double-blind, multicenter study. Anesthesiology 1992 ; 77 : 245-51.
Darmon JY. Required sample-size for randomized clinical trials. Anesthesiology 1993 ; 78 : 610.
Mentec H, Chosidow O, Lafaurie P, Darmon JY, Simon M, Roujeau JC, Brun-Buisson C. Simultaneousarm and leg necrotizing fasciitis due to Neisseria meningitidis : a case report and review of the litera-ture. Ann Dermatol Venerol 1993 ; 120 : 889-91.
Aragao I, Darmon JY, Brun-Buisson C. Adaptation of tissue oxygen extraction in septic and cardioge-nic shock. Rev Portug Med Intens 1993 ; 2 : 19-23.
Dubois-Randé JL, Artigou JY, Darmon JY, Habbal R, Manuel C, Tayarani I, Castaigne A, GrosgogeatY. Oxidative stress in patients with unstable angina. Eur Heart J 1994 ; 15 : 179-83.
Darmon JY. Activateurs des canaux potassiques et pathologie cardiovasculaire. Le nicorandil (IKO-REL®) dans l'insuffisance coronaire. Revue de l'ADPHSO 1994 ; 19 : 91-7.
Witchitz S, Darmon JY. Nicorandil safety in the long term treatment of coronary heart disease. Cardiovasc Drugs Ther 1995 ; 9 : 237-43.
Lenique F, Teboul JL, Darmon JY, Mercat A, Richard C. Evaluation of haemodynamic and oxygen-deri-ved parameters to predict outcome in patients with acute heart failure. Clinical Intensive Care 1995 ;6 : 148-52.
Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis afterhospital discharge in patients having undergone total hip replacement : randomised comparison ofenoxaparin versus placebo. Lancet 1996 ; 348 : 224-28.
Planes A, Vochelle N, Darmon JY. Post-discharge deep-vein thrombosis after orthopaedic surgery. Lancet 1996 ; 348 : 117.
Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Jambon C, Leizorovicz A, Nguyen H,Olsson CG, Turpie AG, Weisslinger N. A comparison of enoxaparin with placebo for the prevention ofvenous thromboembolism in acutely ill medical patients. N Engl J Med 1999 ; 341 : 793-800.
Witchitz S, Cohen-Solal A, Dartois N, Weisslinger N, Juste K, Darmon JY, for the CELICARD Group. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodila-tory properties. Am J Cardiol 2000 ; 85 : 1467-71.
Samama MM for the Sirius Study Group , Darmon JY, De Vathaire F, Huet Y, Landauer D, Samama MM,Simonneau G, Wainstein JP, Weisslinger N. An epidemiologic study of risk factors for dep vein thrombo-sis in medical outpatients. The Sirius Study. Arch Intern Med 2000 ; 160 : 3415-20.
Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weightheparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001 ;88 :1-18.
Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, Priollet P, Cohen C, YvelinN, Schved JF, Tournaire M, Borg JY. Venous thromboembolism during pregnancy : a retrospectve studyof enoxaparin in 624 pregnancies. Br J Obstet Gynaecol 2001 ; 108 : 1134-40.
Purchase of Medicine under Rate Contract New Forest Hospital Forest Research Institute P.O. New Forest Dehra Dun – 248 006 NEW FOREST HOSPITAL FOREST RESEARCH INSTITUTE (Indian Council of Forestry Research & Education) P.O. New Forest, Dehra Dun - 248 006 Phone : 0135-2772158 , 2224609, 2224648 TENDER DOCUMENT Tender No. : FRI-DDN/7
1. NIDA CTN 0051: A Multi-site Randomized Controlled Evaluation of Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT). (LIs Rotrosen & Nunes). This study will assess the comparative effectiveness of extended release injectable naltrexone (XR-NTX, Vivitrol®) versus buprenorphine naloxone (BUP-NX, Suboxone®) as pharmacotherapeutic aids to recovery amongst treatment-